Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells

K. Tajima, R. Ohashi, Y. Sekido, T. Hida, T. Nara, M. Hashimoto, S. Iwakami, K. Minakata, T. Yae, F. Takahashi, H. Saya, K. Takahashi

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Malignant pleural mesothelioma (MPM) is resistant to chemotherapy and thus shows a dismal prognosis. Osteopontin (OPN), a secreted noncollagenous and phosphoprotein, is suggested to be involved in the pathogenesis of MPM. However, the precise role of OPN, especially in the multidrug resistance of MPM, remains to be elucidated. We therefore established stable transfectants (ACC-MESO-1/OPN), which constitutively express OPN, to determine its role in the chemoresistance observed in MPM. The introduction of the OPN gene provides MPM cells with upregulated multidrug resistance through the mechanism of enhanced hyaluronate (HA) binding. The expression of CD44 variant isoforms, which inhibit HA binding, significantly decreased in ACC-MESO-1/OPN cells in comparison to control transfectants. Interestingly, the inhibition of the HA-CD44 interaction abrogated multidrug resistance in the ACC-MESO-1/OPN, thus suggesting the involvement of the surviving signal emanating from the HA-CD44 interaction. An enhanced level of the p-Akt in ACC-MESO-1/OPN cells was observed, and was diminished by CD44 siRNA. Inhibition of the Akt phosphorylation increased in number of the cells underwent apoptosis induced by NVB, VP-16 and GEM. Collectively, these results indicate that OPN is strongly involved in multidrug resistance by enhancing the CD44 binding to HA.

Original languageEnglish
Pages (from-to)1941-1951
Number of pages11
JournalOncogene
Volume29
Issue number13
DOIs
Publication statusPublished - 2010 Apr 1

Keywords

  • CD44
  • Hyaluronan
  • Mesothelioma
  • Multidrug resistance
  • Osteopontin

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Fingerprint Dive into the research topics of 'Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells'. Together they form a unique fingerprint.

  • Cite this

    Tajima, K., Ohashi, R., Sekido, Y., Hida, T., Nara, T., Hashimoto, M., Iwakami, S., Minakata, K., Yae, T., Takahashi, F., Saya, H., & Takahashi, K. (2010). Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells. Oncogene, 29(13), 1941-1951. https://doi.org/10.1038/onc.2009.478